Uroplasty (NSDQ:UPI) named Brett Reynolds to head its vacant finance chief position, drawing the new executive from his most recent gig as CFO at Baxter– (NYSE:BAX)acquired Synovis Life Technologies.
While at Synovis, Reynolds guided the company through last year’s $325 million acquisition. He’s also worked for Chiquita Processed Foods, Arthur Andersen and Deloitte & Touche in various finance roles.
"His track record of building strong financial organizations and processes expands the depth of our executive leadership team and we are delighted to have him on board in this key role," said Uroplasty CEO Rob Kill in prepared remarks.
Tissue Regenix names a VP to market its dCell device in the U.S.
Tissue Regenix put Kevin Barton on-point to direct U.S. sales and marketing for its dCell tissue regeneration device. The company’s new marketing VP hails from a wound care company Kinetic Concepts , where he was a senior product manager. Barton also formerly worked at Novartis, Sulzer Carbomedics and Dell Computer Corp.
Read more
Solta Medical international VP gets promoted to global VP
Solta Medical (NSDQ:SLTM) moved Mingo Ku up in the ranks from his former role as international VP to the new role as global sales VP. Ku joined Solta 5 years ago as the managing director of Asian operations, and Solta said that since his tenure the company has seen double-digit sales growth for non-surgical products. As VP of global sales, Ku will be in charge of all non-surgical devices for the medical aesthetics company.
Read more
Greatbatch CEO lands a new $700k base salary contract
Greatbatch (NYSE:GB) inked a new 3-year contract with CEO Thomas Hook that awards the executive a $700,000 base salary, plus benefits. The employment contract will go back to the board for review in August of 2016 and includes optional renewal. Before taking the reigns at Greatbatch, Hook worked in executive roles at CTI Solutions and GE Healthcare (NYSE:GE).
Read more
Former White House advisor moves to private consulting
The investment firm Consonance Capital Partners hired former White House advisor Nancy DeParle as a partner. The firm invests in U.S healthcare companies, and DeParle’s role as deputy chief of staff of policy at the White House was largely to help roll out Obamacare. She formerly worked for JP Morgan Chase from 2001-2009 and worked as the director of CMS during the Clinton years, back when the agency was still called the Health Care Financing Administration.
Read more
